Thus, Hunder et al. provided evidence with a single case of effective adoptive T cell therapy utilizing NY-ESO-1-specific CD4+ T cells cultured with IL-7 and IL-2 for the treatment of a patient with metastatic melanoma who had not received prior lymphodepletion or vaccination therapy [49]. This evidence concerns the gene CD4 and metastatic melanoma.